{"url":"https://lda.senate.gov/api/v1/filings/9c19e93c-c8bb-4078-ab73-e33708a4bd0f/","filing_uuid":"9c19e93c-c8bb-4078-ab73-e33708a4bd0f","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/9c19e93c-c8bb-4078-ab73-e33708a4bd0f/print/","filing_document_content_type":"text/html","income":"70000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Molly Ford","dt_posted":"2026-04-20T15:12:52-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2001 K Street, NW","registrant_address_2":"Third Floor North","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":35684,"url":"https://lda.senate.gov/api/v1/registrants/35684/","house_registrant_id":31728,"name":"SMITHBUCKLIN CORPORATION","description":"Trade association","address_1":"2001 K Street, NW","address_2":"Third Floor North","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MOLLY FORD","contact_telephone":"+1 202-367-1100","dt_updated":"2026-07-28T15:46:16.782370-04:00"},"client":{"id":144309,"url":"https://lda.senate.gov/api/v1/clients/144309/","client_id":1003907,"name":"ASTCT","general_description":"Healthcare Society","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-02-25"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications Revaccination of Immunosuppressed Patients H.R. 1509/S. 752, The Accelerating Kids Access to Care Act H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141242,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":"GIAMMARCO","middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"- CMS coding and billing clarity for CAR-T therapies - CMS engagement on MS-DRG 018 for CAR-T therapies - H.R. 1509/S. 752, the Accelerating Kids Access to Care Act - H.R. 2491/S. 1227, the Alleviating Barriers to Care Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141242,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":"GIAMMARCO","middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"- Labor-HHS Appropriations - CAR-T Therapy clarification","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141242,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":"GIAMMARCO","middle_name":null,"last_name":"FORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}